Drugs That Cause Pupillary Dilation
Anticholinergic medications are the primary class of drugs that cause pupillary dilation, with adrenergic agents being another significant category. 1
Anticholinergic Medications
- Scopolamine causes pupillary dilation with side effects including blurred vision, dry mouth, and urinary retention 1, 2
- Tropicamide (ophthalmic drops) causes significant pupillary dilation and is commonly used for eye examinations 3
- Cyclopentolate (ophthalmic drops) causes stronger and longer-lasting pupillary dilation than tropicamide 3
- Atropine (both systemic and ophthalmic) causes pupillary dilation, though intravenous atropine at doses used in dobutamine stress echocardiography (0.25-0.75 mg) may not significantly affect pupil size in adults without glaucoma 4, 5
- Other anticholinergic medications including tricyclic antidepressants and certain psychiatric medications can cause pupillary dilation 1, 6
Adrenergic/Sympathomimetic Agents
- Phenylephrine (ophthalmic drops) causes pupillary dilation through direct sympathomimetic action 6, 3
- Epinephrine (systemic) can cause pupillary dilation, particularly when used for anaphylactic shock 6
- Nasal decongestants containing ephedrine can cause pupillary dilation 6
- Nebulized salbutamol (albuterol) has been reported to cause pupillary dilation 6
Clinical Implications
- Pupillary dilation from these medications can precipitate acute angle-closure glaucoma in susceptible individuals with narrow iridocorneal angles 1, 6
- The mydriatic effect of scopolamine specifically may increase intraocular pressure resulting in acute angle closure glaucoma 2
- Patients with primary angle-closure suspect (PACS) should be warned about the risk of using medications that cause pupillary dilation 1
- Symptoms of acute angle closure glaucoma include eye pain, blurred vision, visual halos, and red eyes 2
Risk Assessment and Precautions
- High-risk eyes (those with narrow angles) should never be dilated with cyclopentolate due to higher risk of angle closure 3
- Tropicamide is generally safer but still requires precautions in patients with narrow angles 3
- Phenylephrine-induced mydriasis followed by miosis with thymoxamine drops is considered safest for high-risk patients 3
- Patients with known narrow angles should be monitored for intraocular pressure changes when receiving medications with mydriatic effects 6
Monitoring and Management
- Monitor intraocular pressure in patients with open-angle glaucoma when using medications with mydriatic effects 2
- Advise patients to immediately discontinue medications and seek medical attention if they experience symptoms of acute angle closure 2
- Treatment of medication-induced angle closure typically includes intravenous acetazolamide and pilocarpine to rapidly normalize pressure 3
- For patients requiring diagnostic pupillary dilation who are at risk for angle closure, ophthalmology consultation should be considered before administration 6, 3